UNCY compared with TLPH: revenue, margins and what each company keeps, and the suppliers and customers both name

UNCYUnicycive Therapeutics, Inc.

Mkt capRevenueRevenue

TLPHTalphera, Inc.

Mkt capRevenueRevenue

Compare

UNCYUnicycive Therapeutics, Inc.

TLPHTalphera, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

UNCYUnicycive Therapeutics, Inc.

3.62▲+3.83%

Mkt cap$93.9MRevenue—

TLPHTalphera, Inc.

1.05▲+3.96%

Regular sessionNov 3 '26

Mkt cap$52.4MRevenue$1,000Q3 FY25

Compare

Regular sessionNov 3 '26

UNCYUnicycive Therapeutics, Inc.

TLPHTalphera, Inc.

3.62▲+3.83%

Price

1.05▲+3.96%

$93.9M

Mkt cap

$52.4M

—

Revenue

$1,000Q3 FY25

UNCY3.62▲+3.83%vsTLPH1.05▲+3.96%Regular sessionNov 3 '26

Earnings history

last 4 reports each · paired by recencyMethod ›

UNCY1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.0%▲+7.80%×0.65

TLPH1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±72.1%▼−13.57%×0.19

= impliedUNCY realized, solidTLPH realized, hatchedOne scale, both sides: full bar = 73%× = |realized| ÷ impliedSource: market data